(Q39764629)

14 September 2017

1 reference

title

The myelodysplastic syndrome--a practical guide (English)

1 reference

14 September 2017

1

Hamblin TJ

1 reference

14 September 2017

Oscier DG

2

1 reference

14 September 2017

1 January 1987

1 reference

14 September 2017

Hematological Oncology

1 reference

14 September 2017

5

1 reference

14 September 2017

1

1 reference

14 September 2017

19-34

1 reference

Proposals for the classification of the myelodysplastic syndromes

14 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

Danazol therapy in myelodysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

Relapsing polychondritis. Survival and predictive role of early disease manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

Ph1-negative chronic granulocytic leukemia: a nonentity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

Low-dose arabinosyl cytosine in acute leukemia after a myelodysplastic syndrome and in elderly leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

Acquired hemoglobin H disease in a case of refractory anemia with excess of blasts (RAEB) evolving into acute nonlymphoid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

Allogeneic Marrow Transplantation in the Treatment of Preleukemia

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

Differentiation of myeloid leukaemic cells: new possibilities for therapy

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

Low dose arabinosyl cytosine for treatment of myelodysplastic syndromes and subacute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

Glucocorticoid therapy in the preleukemic syndrome (hemopoietic dysplasia): identification of responsive patients using in-vitro techniques

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

Myeloid cell surface phenotype in myelodysplasia: evidence for abnormal persistence of an early myeloid differentiation antigen

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

A myelodysplastic syndrome preceding acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

Philadelphia chromosome in idiopathic acquired sideroblastic anemia

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

Decreased T helper cells in the myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

Granulocyte and monocyte surface membrane markers in the myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

Prognostic importance of hypodiploid hemopoietic precursors in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

Dysmyelopoietic syndromes. A search for prognostic factors in 193 patients

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

Monocytic skin infiltration in chronic myelomonocytic leukaemia

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

Immunological abnormalities in myelodysplastic syndromes. II. Coexistent lymphoid or plasma cell neoplasms: a report of 20 cases unrelated to chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

Skin infiltration associated with chronic myelomonocytic leukaemia.

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

Refractory anaemia with excess of blasts terminating as Ph1 negative chronic myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

Immune abnormalities in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

Acute biphenotypic leukaemia (myeloid and null-ALL type) supervening in a myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

Myelodysplastic syndromes. A clinical and pathologic analysis of 109 cases

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

Synergistic interaction between differentiation inducers and DNA synthesis inhibitors: a new approach to differentiation induction in myelodysplasia and acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

The myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

The preleukemic syndrome: correlation of in vitro parameters of granulopoiesis with clinical features

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

Treatment of preleukemic syndromes with continuous intravenous infusion of low-dose cytosine arabinoside.

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

‘False Positive’ Acidified Serum Test in a Preleukemic Dyserythropoiesis

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

Idiopathic refractory sideroachrestic anemia (IRSA) progressing to acute mixed lymphoblastic-myelomonoblastic leukemia. Case report and review of the literature

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

A therapeutic trial with low-dose cytarabine in myelodysplastic syndromes and acute leukemia

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

Myelodysplastic syndromes: pathogenesis, functional abnormalities, and clinical implications

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

Pyoderma gangrenosum in myelodysplasia and acute leukaemia

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

Utility of the FAB classification for myelodysplastic syndromes: investigation of prognostic factors in 237 cases

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

Natural killer (NK)-cell activity and antibody-dependent cellular cytotoxicity (ADCC) in primary preleukemic syndrome

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

Cytogenetic studies in 174 consecutive patients with preleukemic or myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

Different Blocks in the Differentiation of Myeloid Leukemic Cells

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

Treatment of advanced myelodysplastic syndrome with alfacalcidol

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

Bone Marrow Culture Studies in Refractory Cytopenia and ‘Smouldering Leukaemia’

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

Coexistent myelodysplasia and plasma cell neoplasia

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

Low doses of cytarabine in the treatment of myelodysplastic syndrome and acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

Cytarabine in pre-leukaemia

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

Serous effusions in monocytic leukaemias

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

Myelodysplastic syndromes: a scoring system with prognostic significance

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

Immunological abnormalities in myelodysplastic syndromes. I. Serum immunoglobulins and autoantibodies

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

Primary acquired sideroblastic anaemia associated with chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

T lymphoblastic transformation of refractory anaemia with excess of blasts

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

Very-low-dose cytarabine for elderly patients

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

13-cis retinoic acid treatment for myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

A common progenitor for human myeloid and lymphoid cells

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

Platelet function in the myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

Low-dose cytosine arabinoside in the myelodysplastic syndromes and acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

Erythroid and granulocyte-macrophage colony formation in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

Granulocyte function in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

Detection of Cytochemical and Morphological Anomalies in ‘Preleukemia’

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

Low-dose cytosine arabinoside regimen induced a complete remission with normal karyotypes in a case with hypoplastic acute myeloid leukaemia with No. 8-trisomy: in vitro and in vivo evidence for normal haematopoietic recovery

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

Thrombocytopenia as presenting symptom of preleukaemia in 3 patients.

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

Bone marrow histology in myelodysplastic syndromes. I. Histological findings in myelodysplastic syndromes and comparison with bone marrow smears

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

Bone marrow histology in myelodysplastic syndromes. II. Prognostic value of abnormal localization of immature precursors in MDS.

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

Low dose cytosine arabinoside (Ara C) in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

Prognostic factors in the myelodysplastic syndromes: importance of initial data on peripheral blood counts, bone marrow cytology, trephine biopsy and chromosomal analysis

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

The myelodysplastic syndromes: different evolution patterns based on sequential morphological and cytogenetic investigations

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

The role of aggressive chemotherapy in the treatment of the myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

Myelodysplastic syndromes: a study of 101 cases according to the FAB classification

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

https://api.crossref.org/works/10.1002%2FHON.2900050104

1 reference

7 January 2021

Modifications in the classification of primary myelodysplastic syndromes: the addition of a scoring system.

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

Preleukemia and urticaria pigmentosa followed by acute myelomonoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

Chronic myelodysplastic syndrome: short survival with or without evolution to acute leukaemia

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

Primary acquired sideroblastic anaemia and myeloproliferative disease: a report on three cases

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

Low-dose cytosine arabinoside (Ara-C) therapy in the myelodysplastic syndromes and acute leukemia

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

Response of preleukemic syndromes to continuous infusion of low-dose cytarabine

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

Very-low-dose cytarabine for myelodysplastic syndromes and acute myeloid leukaemia in the elderly

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900050104

7 January 2021

Identifiers

DOI

10.1002/HON.2900050104

1 reference

14 September 2017

1 reference

PubMed ID

3552926